Evofem Biosciences to Participate in Piper Sandler 33rd Annual Healthcare Conference

Rhea-AI Summary

Evofem Biosciences (NASDAQ: EVFM) announced that CEO Saundra Pelletier will participate in a fireside chat and hold one-on-one meetings at the Piper Sandler 33rd Annual Virtual Healthcare Conference from November 29 to December 2, 2021. The pre-recorded chat will be available on demand starting at 10:00 AM ET on November 22, 2021, for 90 days. Evofem focuses on innovative products for women's sexual and reproductive health, highlighted by their FDA-approved product, Phexxi®, a hormone-free contraceptive gel. For more details, visit evofem.investorroom.com/Piper2021.

SAN DIEGO, Nov. 19, 2021 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that Chief Executive Officer Saundra Pelletier will participate in a fireside chat and host one-on-one meetings at the Piper Sandler 33^rd Annual Virtual Healthcare Conference being held from November 29 – December 2, 2021.

The Company's pre-recorded fireside chat will be available for on demand listening beginning at 10:00am ET (7:00am PT) on Monday, November 22, 2021 for 90 days through the Piper Sandler conference site and at https://evofem.investorroom.com/Piper2021.

To request a one-on-one meeting with Evofem during the conference, please contact your Piper Sandler representative.

About Evofem Biosciences
Evofem Biosciences, Inc., (NASDAQ: EVFM) is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (chlamydia and gonorrhea). The Company's first FDA-approved product, Phexxi® (lactic acid, citric acid and potassium bitartrate), is a hormone-free, on-demand prescription contraceptive vaginal gel. It comes in a box of 12 pre-filled applicators and is applied 0-60 minutes before each act of sex. Learn more at phexxi.com and evofem.com.

Phexxi^® is a registered trademark of Evofem Biosciences, Inc.

Investor Relations Contact
Amy Raskopf
Evofem Biosciences, Inc.
araskopf@evofem.com
Mobile: (917) 673-5775

View original content to download multimedia:https://www.prnewswire.com/news-releases/evofem-biosciences-to-participate-in-piper-sandler-33rd-annual-healthcare-conference-301428861.html

SOURCE Evofem Biosciences, Inc.

FAQ

When is Evofem Biosciences participating in the Piper Sandler Healthcare Conference?

Evofem Biosciences will participate in the conference from November 29 to December 2, 2021.

What is the date and time for Evofem's fireside chat?

Evofem's pre-recorded fireside chat will be available on November 22, 2021, at 10:00 AM ET.

How long will the fireside chat be available for on-demand listening?

The fireside chat will be available for 90 days after its release.

What is Phexxi® and how is it used?

Phexxi® is a hormone-free contraceptive vaginal gel that is applied 0-60 minutes before sex.

How can I request a one-on-one meeting with Evofem at the conference?

To request a one-on-one meeting, contact your Piper Sandler representative.